Frontiers in Medicine · Oct 30, 2026
Early-onset gastric cancer burden in China from 1990 to 2023: a systematic analysis based on the global burden of disease study 2023
By Junjun Li, Hao Wu, Haijian Wei et al.
IntroductionEarly-onset gastric cancer (EOGC) affects working-age populations and poses a public health challenge, while comprehensive long-term epidemiological evidence for EOGC in China remains limited. This study aimed to analyze the 1990–2023 epidemiological trends of Chinese EOGC burden, quantify lifestyle-related attributable burden, identify trend inflection points, and predict epidemic trends to support precise prevention strategies.MethodsData on EOGC burden among Chinese residents aged 15–49 years were extracted from the Global Burden of Diseases, Injuries, and Risk Factors Study 2023. We analyzed trends in incidence, mortality, disability-adjusted life years (DALYs), prevalence, and corresponding age-standardized rates (ASRs). Joinpoint regression detected nonlinear temporal trends, and Autoregressive Integrated Moving Average (ARIMA) models forecasted burden trends from 2024 to 2040. We conducted sex- and age-stratified analyses and quantified major modifiable risk factors.ResultsThe overall EOGC absolute burden declined substantially over three decades, with stable prevalence and falling ASRs. Significant demographic disparities existed: males and the 45–49 years subgroup bore higher burden with slower improvement, while adolescents showed emerging carcinogenic risks. Smoking was the dominant risk factor, followed by high sodium diet and high alcohol use. Mortality and DALY rates showed consistent three-stage declines, with a slight incidence rebound after 2020. ARIMA projections predicted sustained improvements through 2040, with persistent sex disparities and male-dominated burden.ConclusionChina's EOGC burden has decreased notably over recent decades. Persistent gender and age disparities and emerging youth risks necessitate targeted lifestyle interventions and prioritized screening for high-risk populations to improve long-term EOGC prevention and control.